Annals of Research in Oncology
Published by Edra
Italy · COVID-19 and healthcare impacts
Journal at a glance
- ISSN
- 27852512
- Publisher
- Edra
- Country
- Italy
- Language
- en
Indexing
Metrics
| Metric | Value | Year | Source |
|---|
| DOIs registered (Crossref) | 127 | 2026 | Crossref |
| DOIs, current year (Crossref) | 48 | 2026 | Crossref |
| Works (OpenAlex) | 127 | 2026 | OpenAlex |
| Citations (OpenAlex) | 159 | 2026 | OpenAlex |
| h-index (OpenAlex) | 5 | 2026 | OpenAlex |
| i10-index (OpenAlex) | 1 | 2026 | OpenAlex |
| 2-year mean citedness (OpenAlex) | 0.604 | 2026 | OpenAlex |
Subjects
- COVID-19 and healthcare impacts
- Economic and Financial Impacts of Cancer
- Advances in Oncology and Radiotherapy
- Ovarian cancer diagnosis and treatment
- COVID-19 Clinical Research Studies
- Glioma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
Articles on PubPorta
The most recent records PubPorta holds for this journal.
Similar journals
- Current Oncology Reports — United States · — · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Glioma Diagnosis and Treatment, 3 shared subjects in total
- Frontiers in Oncology — Switzerland · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Glioma Diagnosis and Treatment
- Biomedicines — Switzerland · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: Cancer Immunotherapy and Biomarkers
- EBioMedicine — Kingdom of the Netherlands · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: Cancer Immunotherapy and Biomarkers
- JNCCN Journal of the National Comprehensive Cancer Network — — · Same subject: Advances in Oncology and Radiotherapy, Same subject: Economic and Financial Impacts of Cancer
- International Journal of General Medicine — New Zealand · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: Cancer Immunotherapy and Biomarkers
Sources: OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05